4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0000899243-20-004522
Chairman sold 20,000 shares at $62.90 ($1,258,000)
- Chairman acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
El-Hibri Fuad · Chairman
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-11 | Exercise or conversion : show line 1 in the form | +6,280 | $25.62 | $160,894 | 1,485,298 | D |
| 2020-02-11 | Sale : show line 2 in the form | −6,280 | $62.90 | $395,012 | 1,479,018 | D |
| 2020-02-12 | Exercise or conversion : show line 3 in the form | +13,720 | $25.62 | $351,506 | 1,492,738 | D |
| 2020-02-12 | Sale : show line 4 in the form | −13,720 | $62.90 | $862,988 | 1,479,018 | D |
| Open-market sales · 20,000 sh · avg $62.90 · $1,258,000 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-11 | Exercise or conversion : show line 5 in the form Employee Stock Options (Right to Buy) | −6,280 | 57,038 | D |
| 2020-02-12 | Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) | −13,720 | 43,318 | D |
Loading xslF345X03/doc4.xml…